cetylpyridinium chloride anhydrous has been researched along with HTLV-II Infections in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Adediran, A; Ajibola, S; Akinbami, A; Dada, A; Dosunmu, A; Durojaiye, I; Odesanya, M; Okunoye, O; Oshinaike, O; Uche, E | 1 |
1 other study(ies) available for cetylpyridinium chloride anhydrous and HTLV-II Infections
Article | Year |
---|---|
Seroprevalence of human T lymphotropic virus antibodies among healthy blood donors at a tertiary centre in Lagos, Nigeria.
Topics: Adult; Blood Donors; Cross-Sectional Studies; Female; Health; HTLV-I Antibodies; HTLV-I Infections; HTLV-II Antibodies; HTLV-II Infections; Human T-lymphotropic virus 1; Human T-lymphotropic virus 2; Humans; Male; Middle Aged; Nigeria; Seroepidemiologic Studies; Tertiary Care Centers; Young Adult | 2014 |